Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
Abattis Bioceuticals Market Cap
Abattis Bioceuticals has a market cap or net worth of $476.00 as of April 25, 2025.
Market Cap
476.00
Enterprise Value
n/a
Revenue
269.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 476.00, a decrease of -99.97%. That is a compound annual growth rate of -47.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.63B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 746.57M |
Glass House Brands | 500.84M |
Northwest Biotherapeutics | 443.51M |
Elite Pharmaceuticals | 439.57M |
CytoDyn | 284.32M |
BioStem Technologies | 245.41M |